PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.\', \'Human Immunology Section, Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.\', \'Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.\', \'Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.\', \'The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.\', \'Oral and Maxillofacial Department, Galilee Medical Center, Nahariya, Israel.\', \'Clinical Laboratories Division, Clinical Biochemistry and Endocrinology Laboratory, Galilee Medical Center, Naharia, Israel.\', \'Sheba Medical Center, Ramat Gan, Israel.\', \'Sackler Medical School, Tel Aviv university, Tel Aviv, Israel.\', \'Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.\', \'SeqLL, Woburn, MA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0255096
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34310620
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Unified platform for genetic and serological detection of COVID-19 with single-molecule technology.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all